Page 1 of 199
NUR 521 EXAM 4 COMPREHENSIVE
QUESTION BANK
ADVANCED PHARMACOLOGY |
UNIVERSITY OF ALABAMA CAPSTONE
COLLEGE OF NURSING
2026-2027 ACADEMIC YEAR | 250+
PREMIUM PRACTICE QUESTIONS WITH
RATIONALES
# SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
## Questions 1-30
### Question 1
A patient with liver cirrhosis is prescribed a prodrug that requires hepatic activation. Which
pharmacokinetic alteration would most likely affect this patient's therapeutic response?
A. Increased renal excretion of the active metabolite
B. Decreased conversion of the prodrug to its active form
C. Enhanced first-pass metabolism in the intestines
D. Increased plasma protein binding of the prodrug
**Correct Answer: B**
,Page 2 of 199
**Rationale:** The liver is the primary site of drug metabolism, including the conversion of
prodrugs to their active metabolites. In liver cirrhosis, hepatic enzyme function is reduced,
leading to decreased ability to convert the prodrug to its active form. This results in reduced
therapeutic response despite adequate dosing. Option A is incorrect because renal excretion is not
the primary issue with prodrug activation. Option C is incorrect because first-pass metabolism is
also reduced in cirrhosis. Option D is incorrect because protein binding is typically decreased in
liver disease due to reduced albumin production.
**Distractor Analysis:**
- **A:** Renal excretion affects elimination of active metabolites, not the conversion of
prodrugs. While renal function may be affected in some patients, it is not the primary concern
with prodrug activation in cirrhosis.
- **C:** First-pass metabolism does occur in the intestines and liver, but cirrhosis reduces rather
than enhances this process.
- **D:** Plasma protein binding is generally decreased in liver disease due to reduced albumin
synthesis, not increased.
---
### Question 2
A drug follows zero-order kinetics. After doubling the dose, what happens to the drug's half-life?
A. The half-life remains unchanged
B. The half-life decreases proportionally
C. The half-life increases because clearance is saturated
D. The half-life becomes unpredictable
**Correct Answer: C**
**Rationale:** In zero-order kinetics, a constant amount of drug is eliminated per unit time
rather than a constant fraction. When the dose is doubled, clearance becomes saturated, and the
,Page 3 of 199
half-life increases because the elimination rate cannot keep pace with the increased drug
concentration. This is clinically important for drugs like phenytoin and alcohol, where small dose
increases can lead to disproportionate increases in drug concentration and toxicity.
**Distractor Analysis:**
- **A:** This would be true for first-order kinetics, where half-life is constant regardless of
dose. Zero-order kinetics behave differently.
- **B:** Half-life does not decrease; it increases when clearance is saturated.
- **D:** While zero-order kinetics can be more complex, the half-life predictably increases
when clearance is saturated.
---
### Question 3
A patient's blood work shows a low serum albumin level. The patient is receiving a drug that is
normally 95% protein bound. What should the nurse monitor for?
A. Decreased drug efficacy
B. Signs of drug toxicity
C. Allergic reaction to the drug
D. Increased renal excretion of the drug
**Correct Answer: B**
**Rationale:** Low serum albumin means fewer protein-binding sites are available for drug
binding. This results in a higher concentration of free (unbound) drug in the circulation, which is
the pharmacologically active form. The increased free drug concentration can lead to enhanced
drug effects and potential toxicity. The nurse should monitor for signs of toxicity, especially for
drugs with a narrow therapeutic index.
, Page 4 of 199
**Distractor Analysis:**
- **A:** Decreased efficacy is unlikely; in fact, efficacy may increase due to more free drug
available.
- **C:** Allergic reactions are not directly related to protein binding alterations.
- **D:** Renal excretion may be affected indirectly, but the primary concern is increased free
drug concentration and toxicity.
---
### Question 4
A drug has a volume of distribution (Vd) of 40 L. What does this suggest about the drug's
distribution?
A. The drug is primarily confined to the plasma compartment
B. The drug is extensively distributed into tissues
C. The drug is highly protein bound in the plasma
D. The drug is eliminated primarily by the kidneys
**Correct Answer: B**
**Rationale:** A volume of distribution of 40 L suggests extensive tissue distribution beyond
the plasma and extracellular fluid compartments. Total body water is approximately 42 L, so a
Vd of 40 L indicates that the drug distributes widely into tissues. Drugs with large Vd values are
typically lipophilic and extensively bound to tissue proteins, resulting in long elimination half-
lives.
**Distractor Analysis:**
- **A:** Drugs confined to the plasma compartment would have a Vd of approximately 3-4 L.
- **C:** While protein binding can affect Vd, a Vd of 40 L primarily indicates tissue
distribution.
NUR 521 EXAM 4 COMPREHENSIVE
QUESTION BANK
ADVANCED PHARMACOLOGY |
UNIVERSITY OF ALABAMA CAPSTONE
COLLEGE OF NURSING
2026-2027 ACADEMIC YEAR | 250+
PREMIUM PRACTICE QUESTIONS WITH
RATIONALES
# SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS
## Questions 1-30
### Question 1
A patient with liver cirrhosis is prescribed a prodrug that requires hepatic activation. Which
pharmacokinetic alteration would most likely affect this patient's therapeutic response?
A. Increased renal excretion of the active metabolite
B. Decreased conversion of the prodrug to its active form
C. Enhanced first-pass metabolism in the intestines
D. Increased plasma protein binding of the prodrug
**Correct Answer: B**
,Page 2 of 199
**Rationale:** The liver is the primary site of drug metabolism, including the conversion of
prodrugs to their active metabolites. In liver cirrhosis, hepatic enzyme function is reduced,
leading to decreased ability to convert the prodrug to its active form. This results in reduced
therapeutic response despite adequate dosing. Option A is incorrect because renal excretion is not
the primary issue with prodrug activation. Option C is incorrect because first-pass metabolism is
also reduced in cirrhosis. Option D is incorrect because protein binding is typically decreased in
liver disease due to reduced albumin production.
**Distractor Analysis:**
- **A:** Renal excretion affects elimination of active metabolites, not the conversion of
prodrugs. While renal function may be affected in some patients, it is not the primary concern
with prodrug activation in cirrhosis.
- **C:** First-pass metabolism does occur in the intestines and liver, but cirrhosis reduces rather
than enhances this process.
- **D:** Plasma protein binding is generally decreased in liver disease due to reduced albumin
synthesis, not increased.
---
### Question 2
A drug follows zero-order kinetics. After doubling the dose, what happens to the drug's half-life?
A. The half-life remains unchanged
B. The half-life decreases proportionally
C. The half-life increases because clearance is saturated
D. The half-life becomes unpredictable
**Correct Answer: C**
**Rationale:** In zero-order kinetics, a constant amount of drug is eliminated per unit time
rather than a constant fraction. When the dose is doubled, clearance becomes saturated, and the
,Page 3 of 199
half-life increases because the elimination rate cannot keep pace with the increased drug
concentration. This is clinically important for drugs like phenytoin and alcohol, where small dose
increases can lead to disproportionate increases in drug concentration and toxicity.
**Distractor Analysis:**
- **A:** This would be true for first-order kinetics, where half-life is constant regardless of
dose. Zero-order kinetics behave differently.
- **B:** Half-life does not decrease; it increases when clearance is saturated.
- **D:** While zero-order kinetics can be more complex, the half-life predictably increases
when clearance is saturated.
---
### Question 3
A patient's blood work shows a low serum albumin level. The patient is receiving a drug that is
normally 95% protein bound. What should the nurse monitor for?
A. Decreased drug efficacy
B. Signs of drug toxicity
C. Allergic reaction to the drug
D. Increased renal excretion of the drug
**Correct Answer: B**
**Rationale:** Low serum albumin means fewer protein-binding sites are available for drug
binding. This results in a higher concentration of free (unbound) drug in the circulation, which is
the pharmacologically active form. The increased free drug concentration can lead to enhanced
drug effects and potential toxicity. The nurse should monitor for signs of toxicity, especially for
drugs with a narrow therapeutic index.
, Page 4 of 199
**Distractor Analysis:**
- **A:** Decreased efficacy is unlikely; in fact, efficacy may increase due to more free drug
available.
- **C:** Allergic reactions are not directly related to protein binding alterations.
- **D:** Renal excretion may be affected indirectly, but the primary concern is increased free
drug concentration and toxicity.
---
### Question 4
A drug has a volume of distribution (Vd) of 40 L. What does this suggest about the drug's
distribution?
A. The drug is primarily confined to the plasma compartment
B. The drug is extensively distributed into tissues
C. The drug is highly protein bound in the plasma
D. The drug is eliminated primarily by the kidneys
**Correct Answer: B**
**Rationale:** A volume of distribution of 40 L suggests extensive tissue distribution beyond
the plasma and extracellular fluid compartments. Total body water is approximately 42 L, so a
Vd of 40 L indicates that the drug distributes widely into tissues. Drugs with large Vd values are
typically lipophilic and extensively bound to tissue proteins, resulting in long elimination half-
lives.
**Distractor Analysis:**
- **A:** Drugs confined to the plasma compartment would have a Vd of approximately 3-4 L.
- **C:** While protein binding can affect Vd, a Vd of 40 L primarily indicates tissue
distribution.
